volume 9 issue 5 pages 327-337

DNA topoisomerase II and its growing repertoire of biological functions

John L Nitiss 1
1
 
Molecular Pharmacology Department, Memphis, USA
Publication typeJournal Article
Publication date2009-04-20
scimago Q1
wos Q1
SJR24.378
CiteScore103.8
Impact factor66.8
ISSN1474175X, 14741768
PubMed ID:  19377505
General Environmental Science
General Earth and Planetary Sciences
Abstract
The importance of targeting toposimerase II (TOP2) for the treatment of cancer is not a new concept; however, understanding of the biological functions of this enzyme has lagged behind the use of the drugs to target it. This Review discusses what we now know about the functions of TOP2. DNA topoisomerases are enzymes that disentangle the topological problems that arise in double-stranded DNA. Many of these can be solved by the generation of either single or double strand breaks. However, where there is a clear requirement to alter DNA topology by introducing transient double strand breaks, only DNA topoisomerase II (TOP2) can carry out this reaction. Extensive biochemical and structural studies have provided detailed models of how TOP2 alters DNA structure, and recent molecular studies have greatly expanded knowledge of the biological contexts in which TOP2 functions, such as DNA replication, transcription and chromosome segregation — processes that are essential for preventing tumorigenesis.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
European Journal of Medicinal Chemistry
29 publications, 3.8%
Nucleic Acids Research
24 publications, 3.15%
Nature Communications
20 publications, 2.62%
International Journal of Molecular Sciences
17 publications, 2.23%
Scientific Reports
13 publications, 1.7%
Bioorganic and Medicinal Chemistry
12 publications, 1.57%
Journal of Medicinal Chemistry
11 publications, 1.44%
Molecules
10 publications, 1.31%
Bioorganic Chemistry
10 publications, 1.31%
Journal of Biological Chemistry
10 publications, 1.31%
Biochemistry
9 publications, 1.18%
Chemical Research in Toxicology
9 publications, 1.18%
Bioorganic and Medicinal Chemistry Letters
8 publications, 1.05%
Proceedings of the National Academy of Sciences of the United States of America
8 publications, 1.05%
Oncotarget
7 publications, 0.92%
Pharmaceuticals
7 publications, 0.92%
Journal of Molecular Structure
7 publications, 0.92%
PLoS ONE
7 publications, 0.92%
Biophysical Reviews
6 publications, 0.79%
Molecular Cell
6 publications, 0.79%
Biochemical Pharmacology
6 publications, 0.79%
DNA Repair
6 publications, 0.79%
Cell Cycle
6 publications, 0.79%
eLife
6 publications, 0.79%
Journal of Cell Biology
6 publications, 0.79%
PLoS Genetics
5 publications, 0.66%
Biochemical and Biophysical Research Communications
5 publications, 0.66%
Chemical Communications
5 publications, 0.66%
Methods in Molecular Biology
5 publications, 0.66%
5
10
15
20
25
30

Publishers

20
40
60
80
100
120
140
160
180
200
Elsevier
184 publications, 24.12%
Springer Nature
120 publications, 15.73%
MDPI
66 publications, 8.65%
Wiley
54 publications, 7.08%
American Chemical Society (ACS)
49 publications, 6.42%
Oxford University Press
41 publications, 5.37%
Cold Spring Harbor Laboratory
36 publications, 4.72%
Taylor & Francis
24 publications, 3.15%
Royal Society of Chemistry (RSC)
18 publications, 2.36%
Public Library of Science (PLoS)
14 publications, 1.83%
Bentham Science Publishers Ltd.
11 publications, 1.44%
Frontiers Media S.A.
11 publications, 1.44%
American Association for Cancer Research (AACR)
10 publications, 1.31%
American Society for Biochemistry and Molecular Biology
9 publications, 1.18%
Impact Journals
8 publications, 1.05%
Proceedings of the National Academy of Sciences (PNAS)
8 publications, 1.05%
Spandidos Publications
7 publications, 0.92%
European Molecular Biology Organization
6 publications, 0.79%
eLife Sciences Publications
6 publications, 0.79%
Rockefeller University Press
6 publications, 0.79%
American Society for Pharmacology and Experimental Therapeutics
4 publications, 0.52%
The Company of Biologists
4 publications, 0.52%
Portland Press
4 publications, 0.52%
American Society for Microbiology
4 publications, 0.52%
SAGE
3 publications, 0.39%
American Association for the Advancement of Science (AAAS)
3 publications, 0.39%
Hindawi Limited
3 publications, 0.39%
Pleiades Publishing
3 publications, 0.39%
American Physical Society (APS)
2 publications, 0.26%
20
40
60
80
100
120
140
160
180
200
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
766
Share
Cite this
GOST |
Cite this
GOST Copy
Nitiss J. L. DNA topoisomerase II and its growing repertoire of biological functions // Nature Reviews Cancer. 2009. Vol. 9. No. 5. pp. 327-337.
GOST all authors (up to 50) Copy
Nitiss J. L. DNA topoisomerase II and its growing repertoire of biological functions // Nature Reviews Cancer. 2009. Vol. 9. No. 5. pp. 327-337.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/nrc2608
UR - https://doi.org/10.1038/nrc2608
TI - DNA topoisomerase II and its growing repertoire of biological functions
T2 - Nature Reviews Cancer
AU - Nitiss, John L
PY - 2009
DA - 2009/04/20
PB - Springer Nature
SP - 327-337
IS - 5
VL - 9
PMID - 19377505
SN - 1474-175X
SN - 1474-1768
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2009_Nitiss,
author = {John L Nitiss},
title = {DNA topoisomerase II and its growing repertoire of biological functions},
journal = {Nature Reviews Cancer},
year = {2009},
volume = {9},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1038/nrc2608},
number = {5},
pages = {327--337},
doi = {10.1038/nrc2608}
}
MLA
Cite this
MLA Copy
Nitiss, John L.. “DNA topoisomerase II and its growing repertoire of biological functions.” Nature Reviews Cancer, vol. 9, no. 5, Apr. 2009, pp. 327-337. https://doi.org/10.1038/nrc2608.